Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | CDC25A | P30304 | 5/20 | 0.57 |
| ▸ | CDC25C | P30307 | 5/20 | 0.57 |
| ▸ | ARSA | P15289 | 1/20 | 0.57 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30702421 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL64776 | 0.90 | ALDH1A1 (0.82) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL33372528 | 0.90 | ALDH1A1 (0.82) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL23043820 | 0.81 | ALDH1A1 (0.69) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL3192410 | 0.81 | ALDH1A1 (0.69) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| Phenanthrene SCHEMBL27811748 | 0.80 | IDO1 (0.67) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL22609991 | 0.78 | CES1 (0.81) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL29447251 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL2957612 | 0.78 | ALDH1A1 (0.64) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL6851988 | 0.77 | ALDH1A1 (0.62) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3864002-B1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-27 | — | — | EP | claimed |
| US-20220033345-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2022-02-03 | — | — | US | claimed |
| EP-3864002-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M Innovative Properties Company (US) | 2021-08-18 | — | — | EP | claimed |
| EP-2855010-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2017-12-27 | — | — | EP | claimed |
| US-20140234827-A1 | SSAT mRNA TRANSLATION REPRESSION AND ACTIVATION | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2014-08-21 | — | — | US | claimed |
| WO-2013033597-A1 | SSAT MRNA TRANSLATION REPRESSION AND ACTIVATION | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2013-03-07 | — | — | WO | claimed |
| US-20110224141-A1 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | STC.UNM (US) | 2011-09-15 | — | — | US | claimed |
| US-20090303665-A1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME | SHOWA DENKO K.K. (JP) | 2009-12-10 | — | — | US | claimed |
| WO-2009148623-A2 | METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER | STC.UNM (US) | 2009-12-10 | — | — | WO | claimed |
| EP-0971382-B1 | SOLID ELECTROLYTIC CAPACITOR AND PROCESS FOR THE PRODUCTION THEREOF | SHOWA DENKO KK (JP) | 2009-04-22 | — | — | EP | claimed |
| US-6867241-B2 | Radiation-curable, cyanoacrylate-containing compositions | HENKEL CORPORATION (US) | 2005-03-15 | — | — | US | claimed |
| US-20040034116-A1 | Luminescing and/or fluorescing radiation-curable, cyanoacrylate-containing compositions | HENKEL LOCTITE CORPORATION | 2004-02-19 | — | — | US | claimed |
| US-20030162857-A1 | Radiation-curable, cyanoacrylate-containing compositions | LOCTITE CORPORATION | 2003-08-28 | — | — | US | claimed |
| WO-2003065841-A1 | LUMINESCING AND/OR FLUORESCING RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | HENKEL CORPORATION (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2003064483-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | HENKEL CORPORATION (US) | 2003-08-07 | — | — | WO | claimed |
| US-20020039274-A1 | SOLID ELECTROLYTE LAYER COMPRISES A COMPOSITION CONTAINING A PI -ELECTRON CONJUGATE POLYMER AND/OR OTHER ELECTRICALLY CONDUCTING POLYMER, A CONDENSED HETEROPOLYCYCLIC POLYMER | SHOWA DENKO K.K. | 2002-04-04 | — | — | US | claimed |
| US-20020034060-A1 | VALVE METAL HAVING MICROFINE PORES; DIELECTRIC FILM; LAMELLAR STRUCTURE; HEAT AND STRESS RESISTANCE; WATERPROOFING | SHOWA DENKO K.K. | 2002-03-21 | — | — | US | claimed |
| US-6351370-B1 | Solid electrolytic capacitor and method for producing the same | SHOWA DENKO K.K. (JP) | 2002-02-26 | — | — | US | claimed |
| EP-0971382-A1 | SOLID ELECTROLYTIC CAPACITOR AND PROCESS FOR THE PRODUCTION THEREOF | Showa Denko K K (JP) | 2000-01-12 | — | — | EP | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234827-A1 | SSAT mRNA TRANSLATION REPRESSION AND ACTIVATION | RNMT, RNGTT, SRM | ALDH1A1 1038/4885CYP1A2 4612/4885CYP2C9 4706/4885 |
| US-20220033345-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | PARP1, ETFA, PARP2 | ALDH1A1 732/4885CYP1A2 306/4885CYP2C9 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.